EC Followed Docetaxel Versus ET Followed Capecitabine as Adjuvant Chemotherapy for Node Positive Operable Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Docetaxel|DRUG: Capecitabine|DRUG: Epirubicin|DRUG: Cyclophosphamide
Sponsor: Spanish Breast Cancer Research Group
Collaborators: Sanofi|Hoffmann-La Roche|Pfizer